Provided by Tiger Trade Technology Pte. Ltd.

IDEAYA Biosciences

40.04
+0.37000.93%
Post-market: 40.820.7800+1.95%16:33 EDT
Volume:786.61K
Turnover:31.56M
Market Cap:3.85B
PE:-20.47
High:40.46
Open:39.73
Low:39.12
Close:39.67
52wk High:40.58
52wk Low:23.23
Shares:96.27M
Float Shares:94.37M
Volume Ratio:0.88
T/O Rate:0.83%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9561
EPS(LYR):-1.2849
ROE:-16.22%
ROA:-11.54%
PB:3.22
PE(LYR):-31.16

Loading ...

Wedbush Keeps Their Buy Rating on IDEAYA Biosciences (IDYA)

TIPRANKS
·
Aug 20

Analysts Conflicted on These Healthcare Names: IDEAYA Biosciences (IDYA) and Definitive Healthcare Corp (DH)

TIPRANKS
·
Aug 20

Ideaya Biosciences, Genentech Partner for Pancreatic Cancer Trial

MT Newswires Live
·
Aug 19

Ideaya Biosciences enters IDE892 collaboration with Genentech

TIPRANKS
·
Aug 19

Ideaya Biosciences Teams with Genentech to Test Ide892 with KRAS G12D Drug in Pancreatic Cancer

Reuters
·
Aug 19

Ideaya Biosciences - to Supply Ide892 for Clinical Trial

THOMSON REUTERS
·
Aug 19

Ideaya Biosciences - Plans to Initiate a Phase 1 Combination Cohort with Roche's Rg6505 in Mtap-Deleted, Ras-Mutant Pdac in 2H 2026

THOMSON REUTERS
·
Aug 19

Ideaya Biosciences Announces Clinical Collaboration with Genentech in Mtap-Deleted Kras G12d-Mutant Pancreatic Cancer

THOMSON REUTERS
·
Aug 19

Ideaya Biosciences - Co and Genentech Retain All Commercial Rights to Their Compounds

THOMSON REUTERS
·
Aug 19

Ideaya Biosciences, - Genentech to Sponsor Clinical Trial with Joint Governance

THOMSON REUTERS
·
Aug 19

LifeSci Capital Sticks to Its Buy Rating for IDEAYA Biosciences (IDYA)

TIPRANKS
·
Aug 08

Ideaya Biosciences price target lowered to $42 from $45 at Citizens

TIPRANKS
·
Aug 07

IDEAYA Biosciences (IDYA) Receives a Buy from RBC Capital

TIPRANKS
·
Aug 06

Ideaya Biosciences, Inc. : Leerink Partners Cuts Target Price to $31 from $37

THOMSON REUTERS
·
Aug 05

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 05

IDEAYA Biosciences (IDYA) Stock Faces Loss Pressure Despite Revenue Traction

Simply Wall St.
·
Aug 05

Analysts Offer Insights on Healthcare Companies: IDEAYA Biosciences (IDYA) and TransMedics Group (TMDX)

TIPRANKS
·
Aug 05

Wedbush Adjusts Price Target on IDEAYA Biosciences to $60 From $58, Maintains Outperform Rating

MT Newswires Live
·
Aug 04

Ideaya Biosciences Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 04

Earnings Flash (IDYA) IDEAYA Biosciences Posts Q2 Net Loss $1.22 a Share, vs. FactSet Est of $1.18 Loss

MT Newswires Live
·
Aug 04